IRADIMED CORPORATION Incremental Common Shares Attributable to Dilutive Effect of Conversion of Preferred Stock
IRADIMED CORPORATION (IRMD) reported Incremental Common Shares Attributable to Dilutive Effect of Conversion of Preferred Stock of 751.78 thousand shares for the 12-month period ending 2014-12-31, per its 10-K filed 2017-03-10.
Discontinued › Income Statement › Earnings Per Share
us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock · last filed 2017-03-10
- IRADIMED CORPORATION incremental common shares attributable to dilutive effect of conversion of preferred stock for the quarter ending 2014-09-30 was 228.26K shares, a 83.70% decline year-over-year.
- IRADIMED CORPORATION incremental common shares attributable to dilutive effect of conversion of preferred stock for the quarter ending 2014-06-30 was 1.40M shares, a 0.00% change year-over-year.
- IRADIMED CORPORATION incremental common shares attributable to dilutive effect of conversion of preferred stock for the quarter ending 2014-03-31 was 1.40M shares.
- IRADIMED CORPORATION incremental common shares attributable to dilutive effect of conversion of preferred stock for the quarter ending 2013-09-30 was 1.40M shares.
- IRADIMED CORPORATION incremental common shares attributable to dilutive effect of conversion of preferred stock for fiscal 2014 was 751.78K shares, a 46.30% decline from fiscal 2013.
- IRADIMED CORPORATION incremental common shares attributable to dilutive effect of conversion of preferred stock for fiscal 2013 was 1.40M shares.
| Period end | Incremental Common Shares Attributable to Dilutive Effect of Conversion of Preferred Stock 3 month | Incremental Common Shares Attributable to Dilutive Effect of Conversion of Preferred Stock 6 month | Incremental Common Shares Attributable to Dilutive Effect of Conversion of Preferred Stock 9 month | Incremental Common Shares Attributable to Dilutive Effect of Conversion of Preferred Stock 12 month |
|---|---|---|---|---|
| 2014-12-31 | 751.78K shares 10-K · filed 2017-03-10 | |||
| 2014-09-30 | 228.26K shares 10-Q · filed 2015-11-10 | 1.01M shares 10-Q · filed 2015-11-10 | ||
| 2014-06-30 | 1.40M shares 10-Q · filed 2015-08-11 | 1.40M shares 10-Q · filed 2015-08-11 | ||
| 2014-03-31 | 1.40M shares 10-Q · filed 2015-05-11 | |||
| 2013-12-31 | 1.40M shares 10-K · filed 2015-03-23 | |||
| 2013-09-30 | 1.40M shares 10-Q · filed 2014-11-13 | 1.40M shares 10-Q · filed 2014-11-13 | ||
| 2013-06-30 | 1.40M shares 10-Q · filed 2014-08-14 | 1.40M shares 10-Q · filed 2014-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |